Yan Zhang

Yan Zhang has extensive work experience in the biomedical and pharmaceutical industries. Yan is currently working as the Director of International Business Development at Tricol Biomedical, Inc. since November 2019. Prior to this role, they were a Manager at Haisco US Medtech from February 2017 to March 2019, where they played a key role in building and maintaining the company's operations.

Before joining Haisco US Medtech, Yan worked as an Investment Manager at Haisco Pharmaceutical Group CO., LTD, from January 2015 to March 2019. In this role, they were responsible for managing post-investment activities for all portfolio companies and overseeing venture funds with a total capital size of over $100 million. Yan also served as the company's LP representative for its Israel venture fund, reporting directly to the CEO and general VP.

From September 2012 to December 2014, Yan worked as a Business Development Manager at Haisco Pharmaceutical Group Co., LTD. Yan'sresponsibilities included actively seeking new global partners for internal drug research and development in therapeutic areas such as cancer, diabetes, and anesthesia.

Prior to joining Haisco Pharmaceutical Group, Yan worked as a Senior Research Associate at CHARLESSON LLC from July 2010 to July 2012. During this time, they focused on developing drugs to treat diabetes-related retina diseases and led in-vitro and in-vivo drug candidate screening in various models.

Yan's early work experience includes a role as a Technician at the National Institution of Biological Science (NIBS) from July 2006 to June 2007.

Overall, Yan Zhang has a strong background in business development, investment management, and biomedical research, making their a valuable asset in the biomedical and pharmaceutical industries.

Yan Zhang has a diverse education history that spans over multiple years and covers various fields of study. In 2002, they began their undergraduate degree at Beijing Normal University, where they earned a Bachelor of Arts (B.A.) in Biology/Biological Sciences, General. After completing their undergraduate studies in 2006, they pursued their passion for Molecular Biology by enrolling at the University of Oklahoma in 2007. They earned a Master of Arts (M.A.) in Molecular Biology in 2010. With a desire to expand their knowledge beyond the scientific realm, Yan Zhang returned to academia in 2014 and pursued a Master of Business Administration (MBA) at Sichuan University, completing the program in 2016. With this diverse educational background, Yan Zhang possesses a unique blend of scientific expertise and business knowledge.